المؤلفون: Karijn P.M. Suijkerbuijk, Ellen Kapiteijn, John B.A.G. Haanen, Michel W.J.M. Wouters, Michiel C.T. van Zeijl, Gerard Vreugdenhil, Astrid A.M. van der Veldt, Albert J. ten Tije, Rozemarijn S. van Rijn, Djura Piersma, Geke A. Hospers, Jacobus J.M. van der Hoeven, Marye J. Boers-Sonderen, Jan Willem B. de Groot, Alfonsus J.M. van den Eertwegh, Franchette W.P.J. van den Berkmortel, Maureen J.B. Aarts, Christian U. Blank, Anne M. May, Rik J. Verheijden

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::742a384f917f9cb609af63491e5128a5
https://doi.org/10.1158/1078-0432.22477943.v1

المؤلفون: Karijn P.M. Suijkerbuijk, Ellen Kapiteijn, John B.A.G. Haanen, Michel W.J.M. Wouters, Michiel C.T. van Zeijl, Gerard Vreugdenhil, Astrid A.M. van der Veldt, Albert J. ten Tije, Rozemarijn S. van Rijn, Djura Piersma, Geke A. Hospers, Jacobus J.M. van der Hoeven, Marye J. Boers-Sonderen, Jan Willem B. de Groot, Alfonsus J.M. van den Eertwegh, Franchette W.P.J. van den Berkmortel, Maureen J.B. Aarts, Christian U. Blank, Anne M. May, Rik J. Verheijden

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b6e5a41e7d9c2db771ce20ae378f9d
https://doi.org/10.1158/1078-0432.c.6529805

المؤلفون: Maartje G. Schouwenburg, Karijn P.M. Suijkerbuijk, Rutger H.T. Koornstra, Anouk Jochems, Michiel C.T. van Zeijl, Alfons J.M. van den Eertwegh, John B.A.G. Haanen, Maureen J.B. Aarts, Alexander C.J. van Akkooi, Franchette W.P.J. van den Berkmortel, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Wim H. Kruit, Djura Piersma, Rozemarijn S. van Rijn, Albert J. ten Tije, Gerard Vreugdenhil, Jacobus J.M. van der Hoeven, Michel W.J.M. Wouters

المصدر: Cancers; Volume 11; Issue 12; Pages: 1940

مصطلحات موضوعية: melanoma, metastasis, targeted therapy, immune checkpoint inhibitors, lactate dehydrogenase, real-life data, prognostic factors

وصف الملف: application/pdf

Relation: Cancer Therapy; https://dx.doi.org/10.3390/cancers11121940

الاتاحة: https://doi.org/10.3390/cancers11121940

المؤلفون: John B. A. G. Haanen, Maureen J.B. Aarts, Michel W.J.M. Wouters, Albert J. ten Tije, Astrid A M van der Veldt, Karijn P M Suijkerbuijk, Rozemarijn S. van Rijn, Alfons J.M. van den Eertwegh, Liesbeth C. de Wreede, Ellen Kapiteijn, Geke A. P. Hospers, Franchette W P J van den Berkmortel, Jacobus J.M. van der Hoeven, Gerard Vreugdenhil, Michiel C T van Zeijl, Jan-Willem B de Groot, Djura Piersma

المساهمون: Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: International Journal of Cancer, 150(2), 317-326. Wiley-Liss Inc.
International Journal of Cancer, 150(2), 317-326. Wiley
International Journal of Cancer, 150(2), 317-326. WILEY
International Journal of Cancer, 150, 2, pp. 317-326
International Journal of Cancer, 150, 317-326
van Zeijl, M C T, van den Eertwegh, A J M, Wouters, M W J M, de Wreede, L C, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, van der Hoeven, J J M & Haanen, J B A G 2022, ' Discontinuation of anti-PD-1 monotherapy in advanced melanoma—Outcomes of daily clinical practice ', International Journal of Cancer, vol. 150, no. 2, pp. 317-326 . https://doi.org/10.1002/ijc.33800

مصطلحات موضوعية: Male, advanced melanoma, Cancer Research, medicine.medical_specialty, real-world, Skin Neoplasms, Programmed Cell Death 1 Receptor, Ipilimumab, Pembrolizumab, Stable Disease, SDG 3 - Good Health and Well-being, Internal medicine, Medicine, Humans, METASTATIC MELANOMA, Adverse effect, PEMBROLIZUMAB, Immune Checkpoint Inhibitors, Melanoma, Aged, Retrospective Studies, business.industry, Proportional hazards model, IPILIMUMAB, Hazard ratio, Middle Aged, medicine.disease, Prognosis, Discontinuation, Survival Rate, Oncology, Withholding Treatment, SURVIVAL, anti-PD-1, Female, immunotherapy, business, Progressive disease, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, Follow-Up Studies, discontinuation

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aecc11f2696429a42f3b7afc5d49f75
https://hdl.handle.net/11370/0e72933b-593e-414f-b5ab-c29ab695a795

المؤلفون: Anouk Jochems, Esther Bastiaannet, Maureen J.B. Aarts, ACJ Akkooi, F. W.P.J. van den Berkmortel, M. J. Boers-Sonderen, Alphonsus J.M. Van Den Eertwegh, Nienke G. de Glas, Jan-Willem B de Groot, J. B.A.G. Haanen, Geke A.P. Hospers, Jacobus J.M. van der Hoeven, D (Djura) Piersma, Rozemarijn S. van Rijn, Karijn P.M. Suijkerbuijk, Albert J. Ten Tije, A.A.M. (Astrid) van der Veldt, Gerard Vreugdenhil, Michiel C.T. van Zeijl, Ellen W. Kapiteijn, Michel W.J.M. Wouters

المصدر: Journal of Geriatric Oncology vol. 12 no. 7, pp. 1031-1038

Relation: https://repub.eur.nl/pub/136379; urn:hdl:1765/136379

الاتاحة: https://repub.eur.nl/pub/136379
https://doi.org/10.1016/j.jgo.2021.04.006

المؤلفون: Christian U. Blank, Astrid A M van der Veldt, Alfonsus J M van den Eertwegh, Ellen Kapiteijn, Anne M. May, Djura Piersma, Rik J Verheijden, Geke A. P. Hospers, Michel W.J.M. Wouters, Maureen J.B. Aarts, Marye Boers-Sonderen, Karijn P M Suijkerbuijk, Albert J. ten Tije, Franchette W P J van den Berkmortel, Jacobus J.M. van der Hoeven, Rozemarijn S. van Rijn, Jan Willem B. de Groot, Michiel C T van Zeijl, John B. A. G. Haanen, Gerard Vreugdenhil

المساهمون: CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, AII - Cancer immunology, Medical oncology, Radiology & Nuclear Medicine, Medical Oncology, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: ESMO OPEN, 5(6):000945. BMJ Publishing Group
Esmo Open, 5, 6
Esmo Open, 5
ESMO Open, 5(6):e000945. BMJ Publishing Group
ESMO Open, Vol 5, Iss 6 (2020)
ESMO Open, 5(6):000945. BMJ Publishing Group
ESMO Open, 5(6):000945. BMJ PUBLISHING GROUP
Verheijden, R J, May, A M, Blank, C U, van der Veldt, A A M, Boers-Sonderen, M J, Aarts, M J B, van den Berkmortel, F W P J, van den Eertwegh, A J M, de Groot, J W B, van der Hoeven, J J M, Hospers, G A P, Piersma, D, van Rijn, R S, ten Tije, A J, Vreugdenhil, G, van Zeijl, M C T, Wouters, M W J M, Haanen, J B A G, Kapiteijn, E & Suijkerbuijk, K P M 2020, ' Lower risk of severe checkpoint inhibitor toxicity in more advanced disease ', ESMO OPEN, vol. 5, no. 6, 000945 . https://doi.org/10.1136/esmoopen-2020-000945
ESMO Open, 5(6). BMJ PUBLISHING GROUP
ESMO Open

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Programmed Cell Death 1 Receptor, MONOTHERAPY, Disease, Lower risk, lcsh:RC254-282, Gastroenterology, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Antineoplastic Agents, Immunological, Internal medicine, checkpoint inhibition, medicine, melanoma, Humans, immune-related adverse event (irAE), Prospective Studies, Stage (cooking), IMMUNOTHERAPY, anti-PD1, Adverse effect, Lymph node, Original Research, Retrospective Studies, DMTR, Performance status, IMMUNE CHECKPOINTS, business.industry, Melanoma, IPILIMUMAB, NIVOLUMAB, ASSOCIATION, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, CANCER, medicine.anatomical_structure, Oncology, Relative risk, SURVIVAL, Female, ADVERSE EVENTS, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b2810a24d327b462bf0cdb07832e35
https://research.vumc.nl/en/publications/7b0f1470-b2db-489e-b295-a031e5347867

المؤلفون: Edwin Cuppen, Stef van Lieshout, Hendrikus J. Dubbink, Paul Roepman, Marloes Steehouwer, Manon M. H. Huibers, Jacobus J.M. van der Hoeven, Kim Monkhorst, Lieke Schoenmaker, Willemina R. R. Geurts-Giele, Mariëtte E.G. Kranendonk, Bauke Ylstra, Mirjam C. Boelens, Floris H. Groenendijk, Alexander Hoischen, Wendy W.J. de Leng, Ewart de Bruijn, Margaretha G. M. Roemer, Kris G. Samsom

المساهمون: Pathology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers

المصدر: Roepman, P, de Bruijn, E, van Lieshout, S, Schoenmaker, L, Boelens, M C, Dubbink, H J, Geurts-Giele, W R R, Groenendijk, F H, Huibers, M M H, Kranendonk, M E G, Roemer, M G M, Samsom, K G, Steehouwer, M, de Leng, W W J, Hoischen, A, Ylstra, B, Monkhorst, K, van der Hoeven, J J M & Cuppen, E 2021, ' Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics ', Journal of Molecular Diagnostics, vol. 23, no. 7, pp. 816-833 . https://doi.org/10.1016/j.jmoldx.2021.04.011
Journal of Molecular Diagnostics, 23, 7, pp. 816-833
Journal of Molecular Diagnostics, 23, 816-833
Journal of Molecular Diagnostics, 23(7), 816-833. Association of Molecular Pathology

مصطلحات موضوعية: 0301 basic medicine, DNA Copy Number Variations, Concordance, lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4], Computational biology, Alphapapillomavirus, Biology, medicine.disease_cause, Polymorphism, Single Nucleotide, Pathology and Forensic Medicine, Fusion gene, 03 medical and health sciences, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, INDEL Mutation, CDKN2A, Predictive Value of Tests, Neoplasms, Gene duplication, Biomarkers, Tumor, medicine, Humans, Indel, Gene, Retrospective Studies, Whole genome sequencing, Mutation, Whole Genome Sequencing, Papillomavirus Infections, Gene Amplification, Reproducibility of Results, Cancer, medicine.disease, Data Accuracy, 030104 developmental biology, 030220 oncology & carcinogenesis, DNA, Viral, Molecular Medicine, Microsatellite, Microsatellite Instability

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e77afd0b0074d49a789ea249d925a6
https://doi.org/10.1101/2020.10.29.20222091

المؤلفون: Gerrit A. Meijer, Lizet E. van der Kolk, Lieke Schoenmaker, Kris G. Samsom, Jacobus J.M. van der Hoeven, Edwin Cuppen, Emile E. Voest, Luuk J. Schipper, Immy Riethorst, Ewart de Bruijn, Paul Roepman, Linda J.W. Bosch, Kim Monkhorst, Tineke E. Buffart

المصدر: Journal of Clinical Oncology. 39:3013-3013

مصطلحات موضوعية: Whole genome sequencing, Cancer Research, Oncology, business.industry, Medicine, Routine clinical practice, Computational biology, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3e60643daf852f081e6bc3155b0ee5b0
https://doi.org/10.1200/jco.2021.39.15_suppl.3013

المؤلفون: Djura Piersma, Margreet G. Franken, Geke A. P. Hospers, Jan Willem B. de Groot, Maureen J.B. Aarts, Rozemarijn S. van Rijn, B Leeneman, Marieke W. J. Louwman, Ellen Kapiteijn, Michel W.J.M. Wouters, Alfons J.M. van den Eertwegh, Willeke A. M. Blokx, Franchette W P J van den Berkmortel, Jacobus J.M. van der Hoeven, Hans Gelderblom, John B. A. G. Haanen, Albert J. ten Tije, Gerard Groenewegen, Gerard Vreugdenhil, M Schouwenburg, Mathilde C. Cardous-Ubbink, A Jochems, Carin A. Uyl-de Groot, Rutger H. T. Koornstra, Wim H. J. Kruit

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Health Technology Assessment (HTA), Medical Oncology, Medical oncology, CCA - Evaluation of Cancer Care, Internal medicine

المصدر: European Journal of Cancer, 72, 156-165. ELSEVIER SCI LTD
Jochems, A, Schouwenburg, M G, Leeneman, B, Franken, M G, van den Eertwegh, A J M, Haanen, J B A G, Gelderblom, H, Uyl-de Groot, C A, Aarts, M J B, van den Berkmortel, F W P J, Blokx, W A M, Cardous-Ubbink, M C, Groenewegen, G, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Koornstra, R H, Kruit, W H, Louwman, M W, Piersma, D, van Rijn, R S, Ten Tije, A J, Vreugdenhil, G, Wouters, M W J M & van der Hoeven, J J M 2016, ' Dutch Melanoma Treatment Registry : Quality assurance in the care of patients with metastatic melanoma in the Netherlands ', European Journal of Cancer, vol. 72, pp. 156-165 . https://doi.org/10.1016/j.ejca.2016.11.021
European Journal of Cancer, 72, 156-165
European Journal of Cancer, 72, 156. Elsevier Limited
European Journal of Cancer, 72, 156-165. Elsevier Ltd.
European Journal of Cancer, 72, pp. 156-165
European Journal of Cancer, 72, 156-165. Pergamon

مصطلحات موضوعية: Male, INDICATORS, Cancer Research, Skin Neoplasms, Quality Assurance, Health Care, Cost-Benefit Analysis, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Population-based, Systemic therapy, VEMURAFENIB, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Health care, Registries, 030212 general & internal medicine, Vemurafenib, Melanoma, MUTATION, Netherlands, education.field_of_study, Middle Aged, OPEN-LABEL, CANCER, Quality assurance, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Oncology, 030220 oncology & carcinogenesis, SAFETY, SURVIVAL, Female, Checkpoint inhibitors, medicine.drug, Adult, medicine.medical_specialty, Registry, Population, Ipilimumab, Cancer Care Facilities, Metastatic melanoma, 03 medical and health sciences, Quality of life (healthcare), Journal Article, medicine, Humans, Intensive care medicine, education, Protein Kinase Inhibitors, Aged, Quality of Health Care, Clinical Audit, business.industry, IPILIMUMAB, Cancer, medicine.disease, Survival Analysis, Surgery, MAP kinase inhibitors, Quality of Life, business, FOLLOW-UP

وصف الملف: application/pdf; image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1864b94a331d5ff1d6b8ce06aeb92b04
https://doi.org/10.1016/j.ejca.2016.11.021

المؤلفون: Djura Piersma, Alfons J.M. van den Eertwegh, Alexander C.J. van Akkooi, Franchette W P J van den Berkmortel, Jacobus J.M. van der Hoeven, John B. A. G. Haanen, Gerard Vreugdenhil, M Schouwenburg, Ellen Kapiteijn, Michel W.J.M. Wouters, Geke A. P. Hospers, Karijn P M Suijkerbuijk, Jan Willem B. de Groot, Willeke A. M. Blokx, Rozemarijn S. van Rijn, Albert J. ten Tije, A Jochems, B Leeneman, Maureen J.B. Aarts, Wim H. J. Kruit, Rutger H. T. Koornstra, Michiel C T van Zeijl, Margreet G. Franken, Marieke W. J. Louwman

المساهمون: Health Technology Assessment (HTA), Medical Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS), CCA - Cancer Treatment and quality of life, Medical oncology, AII - Inflammatory diseases

المصدر: Melanoma Research, 28, 326-332
Melanoma Research, 28, 4, pp. 326-332
Melanoma Research, 28(4), 326-332. Lippincott Williams & Wilkins
Melanoma Research, 28(4), 326-332. LIPPINCOTT WILLIAMS & WILKINS
Melanoma Research, 28(4), 326. Lippincott Williams and Wilkins
Schouwenburg, M G, Jochems, A, Leeneman, B, Franken, M G, van den Eertwegh, A J M, Haanen, J B A G, van Zeijl, M C T, Aarts, M J, van Akkooi, A C J, van den Berkmortel, F W P J, Blokx, W A M, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Koornstra, R H, Kruit, W H, Louwman, M W J, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, Vreugdenhil, G, Wouters, M W J M & van der Hoeven, J J M 2018, ' Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: Prognostic factors associated with clinical outcomes ', Melanoma Research, vol. 28, no. 4, pp. 326-332 . https://doi.org/10.1097/CMR.0000000000000453
Melanoma Research, 28(4), 326-332. Lippincott Williams and Wilkins
Melanoma Research, 28(4), 326-332

مصطلحات موضوعية: Male, Oncology, Cancer Research, Skin Neoplasms, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], MULTICENTER, MUTATION-POSITIVE MELANOMA, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Risk Factors, 030212 general & internal medicine, Neoplasm Metastasis, Vemurafenib, Melanoma, Aged, 80 and over, education.field_of_study, Framingham Risk Score, Middle Aged, OPEN-LABEL, Prognosis, DABRAFENIB, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], clinical practice, SAFETY, 030220 oncology & carcinogenesis, SURVIVAL, Female, vemurafenib, medicine.drug, metastatic melanoma, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, PHASE-3, Population, Antineoplastic Agents, Ipilimumab, Dermatology, risk score, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, education, Aged, business.industry, Proportional hazards model, IPILIMUMAB, prognostic factors, Dabrafenib, medicine.disease, Confidence interval, REGISTRY, FOLLOW-UP, business

وصف الملف: image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2624cc827142bef034456a349c84a18
https://hdl.handle.net/1887/96180

المؤلفون: Judith R. Kroep, An K.L. Reyners, Jacobus J.M. van der Hoeven, Arien R. van Erkel, Toos Daemen, Cornelis J. M. Melief, Sjoerd H. van der Burg, Marij J. P. Welters, Mariëtte I.E. van Poelgeest, Hans W. Nijman, Renske Goedemans, Vincent T.H.B.M. Smit, Saskia J. A. M. Santegoets, Eveline M. Dijkgraaf

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON), Translational Immunology Groningen (TRIGR), Microbes in Health and Disease (MHD)

المصدر: Oncotarget
Oncotarget, 6, 31, pp. 32228-43
Oncotarget, 6(31), 32228-32243
Oncotarget, 6, 32228-43
Oncotarget, 6(31), 32228-32243. Impact Journals LLC

مصطلحات موضوعية: Oncology, p53, Time Factors, Blood transfusion, Colorectal cancer, T-Lymphocytes, medicine.medical_treatment, Platinum Compounds, Deoxycytidine, Polyethylene Glycols, COLORECTAL-CANCER, Antineoplastic Combined Chemotherapy Protocols, SUPPRESSOR-CELLS, CD8(+) T-LYMPHOCYTES, Cells, Cultured, Netherlands, Ovarian Neoplasms, chemoresistance, Middle Aged, SOLID TUMORS, Recombinant Proteins, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], NUDE-MICE, Treatment Outcome, ovarian cancer, LONG PEPTIDE VACCINE, Female, immunotherapy, medicine.drug, medicine.medical_specialty, CARCINOMA, Alpha interferon, Context (language use), Gynecologic oncology, Interferon alpha-2, Cancer Vaccines, DENDRITIC CELLS, Drug Administration Schedule, I INTERFERONS, Lymphocytes, Tumor-Infiltrating, Internal medicine, Biomarkers, Tumor, medicine, Humans, Aged, Chemotherapy, business.industry, Cancer, medicine.disease, Gemcitabine, Surgery, tumor immunity, Drug Resistance, Neoplasm, Feasibility Studies, Clinical Research Paper, Tumor Suppressor Protein p53, INTERFERON-ALPHA, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cba588b086c113d0b4831f8f68b16a
https://doi.org/10.18632/oncotarget.4772

المؤلفون: Elsken van der Wall, Jacobus J.M. van der Hoeven, Nanda C. Krak, Jos W. R. Twisk, Otto S. Hoekstra, Adriaan A. Lammertsma

المساهمون: Methodology and Applied Biostatistics, Radiology and nuclear medicine, Epidemiology and Data Science, Medical oncology, CCA - Innovative therapy, ICaR - Ischemia and repair, Radiology & Nuclear Medicine

المصدر: Krak, N C, van der Hoeven, J J, Hoekstra, O S, Twisk, J W R, van der Wall, E & Lammertsma, A A 2008, ' Blood flow and glucose metabolism in stage IV breast cancer: heterogeneity of response during chemotherapy. ', Molecular Imaging and Biology, vol. 10, no. 6, pp. 356-363 . https://doi.org/10.1007/s11307-008-0163-2
Molecular Imaging and Biology
Molecular Imaging and Biology, 10(6), 356-363. Springer New York

مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, Lymphatic metastasis, Positron emission tomography, medicine.medical_treatment, Bone Neoplasms, Breast Neoplasms, Carbohydrate metabolism, Metastases, Breast cancer, SDG 3 - Good Health and Well-being, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, skin and connective tissue diseases, Aged, Neoplasm Staging, Medicine(all), Chemotherapy, Glucose metabolism, medicine.diagnostic_test, business.industry, Liver Neoplasms, Blood flow, Middle Aged, medicine.disease, Metastatic breast cancer, Glucose, Treatment Outcome, Lymphatic Metastasis, Positron-Emission Tomography, Female, sense organs, business, Stage iv, Blood Flow Velocity, Research Article

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1579ea7339915fa05423fbb6710be028
https://doi.org/10.1007/s11307-008-0163-2

المؤلفون: Elsken van der Wall, Alejandro Mohar, Jose I. Mayordomo, Dolores Gallardo Rincón, Paula R. Pohlmann, Laura Suchil Bernal, Herbert M. Pinedo, Adolfo Fuentes Alburo, Jacobus J.M. van der Hoeven, Jan Buter, Tanja D. de Gruijl

المصدر: Pohlmann, P R, Suchil Bernal, L, Fuentes Alburo, A, Buter, J, Gallardo Rincón, D, Mohar, A, Mayordomo, J I, Van Der Hoeven, J J M, Van Der Wall, E, De Gruijl, T D & Pinedo, H M 2004, ' Prolonged neoadjuvant treatment plus GM-CSF in locally advanced breast cancer : Clinical and biological concepts ', Clinical and Translational Oncology, vol. 6, no. 3, pp. 130-139 . https://doi.org/10.1007/BF02710114

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Cyclophosphamide, business.industry, Angiogenesis, Clinical study design, medicine.medical_treatment, General Medicine, medicine.disease, Regimen, Immune system, Breast cancer, Internal medicine, Immunology, Medicine, Doxorubicin, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa49a77accfe0da39f2f5b9bf115615
https://doi.org/10.1007/bf02710114

المؤلفون: Peter C. Huijgens, Jacobus J.M. van der Hoeven, Pieter G. Raijmakers, Harm van Tinteren, Emile F.I. Comans, Gerrit J.J. Teule, A. Roelof Jonkhoff, Otto S. Hoekstra, Adriaan A. Lammertsma, Josée M. Zijlstra

المصدر: British Journal of Haematology. 123:454-462

مصطلحات موضوعية: Fluorodeoxyglucose, Vincristine, medicine.diagnostic_test, business.industry, Hematology, CHOP, Scintigraphy, medicine.disease, Non-Hodgkin's lymphoma, Lymphoma, Prednisone, Positron emission tomography, medicine, business, Nuclear medicine, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f03a29b7fe9db70d598fa65e4177ea6e
https://doi.org/10.1046/j.1365-2141.2003.04617.x

المؤلفون: Mirjam M. Garvelink, Ellen M. A. Smets, Anne M. Stiggelbout, Arwen H. Pieterse, Ellen G. Engelhardt, J Hanneke C J M de Haes, Jacobus J.M. van der Hoeven

المصدر: Journal of Clinical Oncology, 32(3), 238
Journal of Clinical Oncology

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Pathology, MEDLINE, Antineoplastic Agents, Breast Neoplasms, Risk prediction models, Health Services Misuse, Truth Disclosure, Risk Assessment, Breast cancer, Quality of life, Predictive Value of Tests, Risk Factors, medicine, Humans, Stage (cooking), Intensive care medicine, Neoplasm Staging, Models, Statistical, business.industry, Health Policy, Uncertainty, medicine.disease, Prognosis, Oncology, Data extraction, Chemotherapy, Adjuvant, Predictive value of tests, Quality of Life, Female, Neoplasm Recurrence, Local, Risk assessment, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ec101bdfc27b14f3f6715a2ce14a23
https://pubmed.ncbi.nlm.nih.gov/24344212

المؤلفون: Jacobus J.M. van der Hoeven, Robbert O. Boer, Lawrence R. Bernstein

المصدر: Anti-cancer agents in medicinal chemistry. 11(6)

مصطلحات موضوعية: Sorafenib, DNA Replication, Cancer Research, Pathology, medicine.medical_specialty, Carcinoma, Hepatocellular, chemistry.chemical_element, Administration, Oral, Gallium Radioisotopes, Gallium 67 scan, chemistry.chemical_compound, Ascites, medicine, Organometallic Compounds, Humans, Gallium, Radionuclide Imaging, Aged, Pharmacology, Gallium nitrate, business.industry, Liver Neoplasms, Cancer, medicine.disease, Gallium maltolate, chemistry, Pyrones, Hepatocellular carcinoma, Cancer research, Molecular Medicine, Female, medicine.symptom, Radiopharmaceuticals, business, Cell Division, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d3f09f98f1b96f8e0ef550a59ae3cb
https://pubmed.ncbi.nlm.nih.gov/21554205

المؤلفون: Albert D. Windhorst, Astrid A.M. van der Veldt, Mark Lubberink, Egbert F. Smit, Adriaan A. Lammertsma, N. Harry Hendrikse, Martien P.J. Mooijer, Anneloes Y. Rijnders, Winald R. Gerritsen, Jacobus J.M. van der Hoeven

المساهمون: Internal medicine, Clinical pharmacology and pharmacy, Pulmonary medicine, Radiology and nuclear medicine, Medical oncology, CCA - Disease profiling

المصدر: European Journal of Nuclear Medicine and Molecular Imaging, 37(10), 1950-1958. Springer Verlag
van der Veldt, A A M, Hendrikse, N H, Smit, E F, Mooijer, M P J, Rijnders, A Y, Gerritsen, W R, van der Hoeven, JJM, Windhorst, A D, Lammertsma, A A & Lubberink, J M 2010, ' Biodistribution and radiation dosimetry of C-11-labelled docetaxel in cancer patients ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 10, pp. 1950-1958 . https://doi.org/10.1007/s00259-010-1489-y
European Journal of Nuclear Medicine and Molecular Imaging

مصطلحات موضوعية: Male, Drug, Biodistribution, Drug-Related Side Effects and Adverse Reactions, PET/CT, Metabolic Clearance Rate, media_common.quotation_subject, Docetaxel, Radiation Dosage, urologic and male genital diseases, Pharmacokinetics, Neoplasms, medicine, Humans, Dosimetry, Radiology, Nuclear Medicine and imaging, Carbon Radioisotopes, Radiometry, neoplasms, Cancer, Aged, media_common, PET-CT, medicine.diagnostic_test, business.industry, Radiation dose, organic chemicals, Biological Transport, General Medicine, medicine.disease, [11C]docetaxel, Radiology Nuclear Medicine and imaging, Positron emission tomography, Positron-Emission Tomography, Cancer research, Original Article, Female, Taxoids, Tomography, X-Ray Computed, Nuclear medicine, business, therapeutics, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b801b5d4680ffedae11960c66ad19aa0
https://research.vumc.nl/en/publications/a5837bdf-ef12-415a-ae39-7b2fadcc5394

المؤلفون: Herbert M. Pinedo, Gerrit Jan Schuurhuis, Wouter M.D. Blokhuis, Jan de Jong, Giuseppe Giaccone, Paul A. Maessen, Coenraad K. van Kalken, Jacobus J.M. van der Hoeven, Wim J.F. van der Vijgh

المصدر: European Journal of Cancer and Clinical Oncology. 27:739-744

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Anthracycline, Bepridil, Drug Resistance, Pharmacology, Pharmacokinetics, Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Doxorubicin, Aged, Antibiotics, Antineoplastic, business.industry, Middle Aged, medicine.disease, Endocrinology, Oncology, Heart failure, Toxicity, Drug Evaluation, Verapamil, Female, business, medicine.drug, Epirubicin

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a0869b9caea9afecd8445b3f9a878c
https://doi.org/10.1016/0277-5379(91)90178-g

المؤلفون: Jaana Lahti-Domenici, Laura J. van't Veer, Hugo M. Horlings, Daphne de Jong, Helgi H. Helgason, Arno Floore, Ryan van Laar, Jan-Martijn Kerst, Anke T. Witteveen, Annuska M. Glas, Jelle Wesseling, Jacobus J.M. van der Hoeven, Marc O. Warmoes

المساهمون: Medical oncology laboratory, Pathology, AGEM - Re-generation and cancer of the digestive system, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, CCA - Cancer biology, CCA - Target Discovery & Preclinial Therapy Development, CCA - Biomarkers, CCA - Clinical Therapy Development, AII - Cancer immunology

المصدر: Journal of Clinical Oncology, 26(27), 4435-4441. American Society of Clinical Oncology
Horlings, H M, van Laar, R K, Kerst, J-M, Helgason, H H, Wesseling, J, van der Hoeven, J J M, Warmoes, M O, Floore, A, Witteveen, A, Lahti-Domenici, J, Glas, A M, Van't Veer, L J & de Jong, D 2008, ' Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary ', Journal of Clinical Oncology, vol. 26, no. 27, pp. 4435-4441 . https://doi.org/10.1200/JCO.2007.14.6969

مصطلحات موضوعية: Male, Cancer Research, Pathology, medicine.medical_specialty, Biopsy, Adenocarcinoma, Metastasis, Diagnosis, Differential, Predictive Value of Tests, Medicine, Humans, medicine.diagnostic_test, business.industry, Gene Expression Profiling, Cancer, Middle Aged, medicine.disease, Primary tumor, Immunohistochemistry, Gene expression profiling, Oncology, Predictive value of tests, Neoplasms, Unknown Primary, Female, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3adbc96a98a45ddf1c7931e1dee6e0c
https://pubmed.ncbi.nlm.nih.gov/19114684

المؤلفون: Hans J Braun, Olaf Loosveld, Albert J. ten Tije, Adelheid M. E. van der Torren, Cornelis J. A. Punt, Jacobus J.M. van der Hoeven, Miriam Koopman, Aafk E. H. Honkoop, Frans L. G. Erdkamp, Jaap Wals, Rob L. H. Jansen, Anne May, Peter Nieboer, Veerle A. Derleyn, Lieke H.J. Simkens, Annemieke Cats, Felix E de Jongh, Zoran Erjavec, Linda Mol, Jolien Tol, Geert-Jan Creemers, Janny G. Haasjes, Harm van Tinteren

المساهمون: Graduate School, CCA -Cancer Center Amsterdam, Oncology, RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Lancet, 385(9980), 1843-1852. Elsevier Limited
The Lancet, 385(9980), 1843. Elsevier Limited
Lancet, 385(9980), 1843-1852. Elsevier Science
The Lancet (London), 385, 9980, pp. 1843-52
The Lancet (London), 385, 1843-52

مصطلحات موضوعية: Oncology, Male, Organoplatinum Compounds, Colorectal cancer, Clinical Trial, Phase III, Kaplan-Meier Estimate, Deoxycytidine, law.invention, Randomized controlled trial, law, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, 80 and over, Medicine, Neoplasm Metastasis, Non-U.S. Gov't, Humanized, Aged, 80 and over, Research Support, Non-U.S. Gov't, General Medicine, Middle Aged, Clinical Trial, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Oxaliplatin, Bevacizumab, Multicenter Study, Treatment Outcome, Randomized Controlled Trial, Female, Fluorouracil, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Research Support, Antibodies, Capecitabine, Phase III, Internal medicine, Journal Article, Humans, Aged, Neoplasm Staging, Intention-to-treat analysis, Performance status, business.industry, medicine.disease, Surgery, Regimen, business

وصف الملف: image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d341513745af9240b05212b8aba4b77
https://hdl.handle.net/1874/337788